Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/11/2021 06/14/2021 06/15/2021 06/16/2021 06/17/2021 Date
465.15(c) 470.07(c) 470.08(c) 468.42(c) 486.08(c) Last
1 935 144 1 452 747 1 260 757 1 691 803 2 237 383 Volume
+0.05% +1.06% 0.00% -0.35% +3.77% Change
More quotes
Financials (USD)
Sales 2021 35 666 M - -
Net income 2021 7 175 M - -
Net Debt 2021 10 493 M - -
P/E ratio 2021 27,0x
Yield 2021 0,19%
Sales 2022 35 445 M - -
Net income 2022 6 484 M - -
Net Debt 2022 7 180 M - -
P/E ratio 2022 29,8x
Yield 2022 0,21%
Capitalization 191 B 191 B -
EV / Sales 2021 5,65x
EV / Sales 2022 5,59x
Nbr of Employees 80 000
Free-Float 89,6%
More Financials
Company
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences... 
More about the company
Ratings of Thermo Fisher Scientific
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about THERMO FISHER SCIENTIFIC
06/17THERMO FISHER SCIENTIFIC  : Announces Oncomine Clinical Research Grant Program C..
AQ
06/15THERMO FISHER SCIENTIFIC  : Goldman Sachs Adjusts Price Target on Thermo Fisher ..
MT
06/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
06/10U.S. senator slams Apple, Amazon, Nike, for enabling forced labour in China
RE
06/08THERMO FISHER SCIENTIFIC  : to Present at the Goldman Sachs 42nd Annual Global H..
PR
06/07THERMO FISHER SCIENTIFIC  : Meltwater Premium Client Segment Update - May 2021
AQ
06/04THERMO FISHER SCIENTIFIC  : Nalgene Outdoor and Jill & Ally Partner on Limited E..
AQ
06/04Q LINEA  : Commercial evaluation of the ASTar system in Europe started
AQ
06/02MODERNA  : Announces Agreement with Thermo Fisher Scientific for Fill/Finish Man..
AQ
06/01MODERNA  : Selects Thermo Fisher Scientific for Fill-Finish Sterile Manufacturin..
MT
05/21THERMO FISHER SCIENTIFIC  : Accelerates Complex Materials Research at Monash Uni..
AQ
05/20THERMO FISHER SCIENTIFIC INC.  : Submission of Matters to a Vote of Security Hol..
AQ
05/20THERMO FISHER SCIENTIFIC  : Scientific iFLM Correlative System Enables Light Mic..
AQ
05/20THERMO FISHER SCIENTIFIC  : Report
CO
05/19THERMO FISHER SCIENTIFIC  : Declares Quarterly Dividend
PR
More news
News in other languages on THERMO FISHER SCIENTIFIC
06/15Investor fordert Ablösung von Qiagens Chefkontrolleur Rosen
05/31Börse Stuttgart-News: Euwax Trends
04/29EN DIRECT DES MARCHES  : Total, STMicro, Airbus, Valneva, Unibail, Apple, Facebo..
04/29STOCK MARKET PARIS : Pour la Fed, il est urgent d'attendre
04/19++ Analysen des Tages von Dow Jones Newswires (19.04.2021) +++
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Stock Trading Strategies
THERMO FISHER SCIENTIFIC - 2020
The trend should regain control
BUY
More Stock Trading Analysis
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 552,40 $
Last Close Price 486,08 $
Spread / Highest target 27,6%
Spread / Average Target 13,6%
Spread / Lowest Target -3,31%
EPS Revisions
Managers and Directors
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC4.36%191 043
DANAHER CORPORATION15.73%174 568
INTUITIVE SURGICAL, INC.8.18%103 187
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.7.18%84 096
SIEMENS HEALTHINEERS AG19.08%66 648
ILLUMINA, INC.23.07%65 030